cannabis industry
cannabis industry · page 92
- Companies
MGC Pharmaceuticals breaks into US market with $24 million deal
The firm has secured a $24 million deal for the supply of its cannabis-based products to the US.
- Policy & Regulation
UK drugs policy no longer fit for purpose, says leading criminologist
The Misuse of Drugs Act 1971 has been described as contributing to a “drug apartheid” resulting in a corrupt system discriminating along the lines of class, ethnicity and gender.
- Medical
Aurora fulfils first shipment for French medical cannabis programme
The products are set to be made available to patients in the coming weeks
- Medical
Grow group: innovating cannabis medicines and improving access
Grow Group co-founder and CEO Ben Langley spoke about the company’s aims, cannabis innovation and its plans for expansion.
- Cultivation
Cannabis genetics to be developed for specific healthcare applications
Swiss Life Sciences says it aims to improve on cannabis medicines that are already being successfully used in treatments with elite genetics.
- Cultivation
Could new trichome structure revolutionise cannabis production?
BioHarvest Sciences says the groundbreaking structure is instrumental in the ability to grow trichome cells in bioreactors at scale.
- Uncategorized
Lidl signs million dollar deal to sell cannabis products
The hemp products will not contain any THC or CBD.
- Medical
Flowr and Cookies to bring ultra-premium medical cannabis strains to EU
Flowr will be growing some of the most recognisable cannabis strains in the world, including Gelatti and Pink Runtz, in Portugal.
- Medical
Materia enters agreement with Eurox for cannabis extract distribution
Extracts are currently the fastest growing product in the German medical cannabis market.
- Medical
US cannabis medicine technology to be available for European patients
The products will benefit European patients with rapid on-set effects within five to 15 minutes alongside improved absorption efficiency.
- Companies
CanCoin: a FinTech solution for the European cannabis industry
The CanCoin is developing an entire ecosystem around the token in a bid to revolutionise the European cannabis market.
- CBD Market
Epidyolex receives approval for tuberous sclerosis seizures treatment
The approval applies in England, Wales and Scotland and follows the recent approval of the product in all 27 countries of the European Union.
